Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
New antithrombotic agents: Are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?
European Heart Journal, 06/11/09
Van de Werf F et al. – A review describes the rationale for and current status of trials of new antithrombotic agents in non-ST-elevation acute coronary syndrome.
Methods- Review of new antithrombotic agents in non-ST-elevation acute coronary syndrome
- Antithrombotic therapy: cornerstone of treatment as shown by numerous clinical trials
- Long-term oral antiplatelet therapy targeting specific platelet activation pathways: significant long-term benefit
- Antithrombin use: limited to acute setting
- Long-term dual oral antiplatelet therapy with aspirin and clopidogrel: proven efficacy but residual, considerable morbidity and mortality
- These effects may be partly due to incomplete inhibition of platelet activation and/or lack of long-term anticoagulant therapy
- Improvements in outcomes may be achieved by developing agents to inhibit other platelet activation pathways or by adding new anticoagulants prolonged duration after acute event
Related Articles
Anticoagulation for heart failure: selecting the best therapy
Expert Review of Cardiovascular Therapy, 10/19/09
Relevance Score: 64%
Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug
Atherosclerosis, 10/07/09
Relevance Score: 64%
Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis
Journal of Experimental Medicine, 11/03/09
Relevance Score: 62%
Triple-negative breast cancer—current status and future directions
Annals of Oncology, 11/16/09
Relevance Score: 45%
The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Therapeutics and Clinical Risk Management, 10/07/09
Relevance Score: 45%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Beta-2 agonists in sport. Are the Anti-Doping rules meeting the needs of asthmatic athletes?
British Journal of Sports Medicine, 12/15/09
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Statins for Primary Prevention of Cardiovascular Mortality in Women: A Systematic Review and Meta-Analysis
Preventive Cardiology, 12/15/09
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Patients' experiences with navigation for cancer care
Patient Education and Counselling, 12/15/09
Relation of Nausea and Vomiting in Acute Myocardial Infarction to Location of the Infarct
The American Journal of Cardiology, 12/15/09
Usefulness of Fragmented QRS on a 12-Lead Electrocardiogram in Acute Coronary Syndrome for Predicting Mortality
The American Journal of Cardiology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


